Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive...
Read moreGlaxoSmithKline's ViiV Healthcare has received marketing authorisation from the European Commission (EC) for its Triumeq (dolutegravir 50mg/abacavir 600mg/lamivudine 300mg) tablets...
Read more
Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses...
Read moreLiverpool biotech firm Redx Pharma has signed a “transformational” multi-million pound deal with global pharmaceutical giant AstraZeneca to develop new...
Read moreToday at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed...
Read moreLaw enforcement authorities from Austria, Belgium, Cyprus, France, Hungary, Slovakia, Spain and the United Kingdom, supported by Europol and Eurojust,...
Read moreThe UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment...
Read moreSwiss drugmaker Roche has signed a definitive merger agreement to acquire InterMune for around $8.3bn. As part of the all-cash...
Read moreFOR EU MEDIA ONLY: NOT FOR SWISS/U.S. MEDIA EMA accepts accelerated review for orphan therapy in hard-to-treat thyroid cancer Eisai...
Read moreBrussels-based biopharmaceutical company Union Chimique Belge (UCB) broke ground for a new biotechnology pilot facility in Belgium in June 2010....
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
